NCT06390956
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06390956
Title Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma (PIONEER-MZL)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Narendranath Epperla
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.